Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.

Disease Sites:

Breast

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Harvey, Sara

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

04-11-2018

Trial Type:

Screening

Protocol ID:

ECOGBREEA1151

National Clinical Trial ID:

NCT03233191

Eligibility

Ages Eligible for Study:

45 Years

Genders Eligible for Study:

FEMALE

Accepts Healthy Volunteers?:

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Eligibility